EpCAM participates in CSC phenotypes in vitro and cellular metastasis by enhancing mTOR signalings, such as Akt, mTOR, P70S6K, and 4EBP1 [123], and is also related to survival rate in NPC patients. This evidence concerns the gene MTOR and nasopharyngeal carcinoma.